Dupuytren disease | Dupuytren Research Group

Dupuytren disease

Dupuytren: restoring balance vs. winning the war
On: Jan 10, 2019
By: Charles Eaton

There were a number of responses to the last blog post. Annie Stratton wrote something so insightful I’ve included it with permission at the end of this post. The last post used the analogy of war, the war on Dupuytren. That seemed reasonable for several reasons – the importance of strategy and tactics, the concept of […]

Read more ›
PrecisionFDA Dupuytren Blog
On: Dec 6, 2018
By: Charles Eaton

PrecisionFDA Dupuytren Blog PrecisionFDA https://precision.fda.gov/ is a US Government initiative designed to support cutting-edge genomic research and help researchers collaborate across the globe. As a member of PrecisionFDA, Dupuytren Research Group will use PrecisionFDA cloud hosting to allow authorized researchers around the world to collaborate and analyze data from the International Dupuytren Data Bank (IDDB). Data […]

Read more ›
Happy Birthday, Dupuytren!
On: Oct 5, 2018
By: Charles Eaton

Today Would Have Been Dupuytren’s Birthday Guillaume Dupuytren (10/5/1777 – 2/8/1835) was born on this day in Pierre-Buffières, France. He excelled in anatomic studies and was appointed assistant surgeon at the Hôtel-Dieu in Paris at the age of 26. He rose to the position of head surgeon at the Hôtel-Dieu and remained so until his […]

Read more ›
Women with Dupuytren disease
On: Oct 4, 2018
By: Charles Eaton

Women with Dupuytren Disease A traditional Dupuytren narrative is that Dupuytren is primarily a painless nuisance problem of bent fingers in old men. This perception does a disservice to many. Not only is Dupuytren common in women, it may also present a unique burden to women. Updating the traditional narrative is central to raising awareness […]

Read more ›
How common is Dupuytren Disease?
On: Apr 1, 2017
By: Charles Eaton

How common is Dupuytren disease? The short answer is this:  much more common than you might think. Scroll to the bottom to get the summary numbers. For the long answer, keep reading. The details depend on where you get your data. One set of data comes from a large web-based survey (DiBenedetti 2010). One conclusion […]

Read more ›
Dupuytren Disease Awareness Day!
On: Mar 20, 2017
By: Charles Eaton

Dupuytren Awareness Dupuytren disease research has a big problem: lack of awareness. Most people have never heard the word “Dupuytren”, much less “Dupuytren Disease”. The name “Dupuytren” is hard to pronounce and even harder to spell. Many other medical conditions have had this problem. Most have still not made it out into public. It takes work, […]

Read more ›
Dupuytren Foundation 2016 Mid-Year Report
On: Aug 30, 2016
By: Charles Eaton

Dupuytren Foundation 2016 Mid-Year Report 2016 has already exceeded expectations for the Dupuytren Foundation. Here are some of the highlights. Progress on International Dupuytren Data Bank Research The International Dupuytren Data Bank (IDDB) launched in November 2015. The goal of the IDDB is a cure for Dupuytren disease. This research has been made possible through your support. Project […]

Read more ›
Media coverage of Dupuytren Disease
On: Apr 18, 2016
By: Charles Eaton

There’s a been recent storm of Dupuytren related media coverage: A television news story interviewing Dupuytren Foundation executive director Dr. Charles Eaton and Dupuytren Foundation board member Tom Knapp: http://www.wpbf.com/news/whats-brewing-with-stephanie-berzinski-dupuytren-disease/39025076 Google books chose the chapter on Dupuytren disease authored by Dr. Charles Eaton to be the online example for the latest edition of the classic […]

Read more ›
First Dupuytren Nodule

My first Dupuytren palm nodule. What will to happen to me? Most Dupuytren disease starts as a nodule. Some nodules go away without any treatment. Some nodules develop minor cords and then seem to stop. Some nodules are the first sign of severe Dupuytren disease. Which is it going to be? Without a biomarker, we can […]

Read more ›